Works matching IS 14363291 AND DT 2011 AND VI 14 AND IP 1

Results: 13

Trans-vaginal specimen extraction following totally laparoscopic subtotal gastrectomy in early gastric cancer.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 91, doi. 10.1007/s10120-011-0006-8

By:

Sang-Ho Jeong;
Young-Joon Lee;
Choi, Won J.;
Paik, Won Y.;
Chi-Young Jeong;
Soon-Tae Park;
Sang-Kyung Choi;
Soon-Chan Hong;
Eun-Jung Jung;
Young-tae Joo;
Woo-Song Ha

Publication type:

Article

Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 41, doi. 10.1007/s10120-011-0004-x

By:

Uchikado, Yasuto;
Okumura, Hiroshi;
Ishigami, Sumiya;
Setoyama, Tetsuro;
Matsumoto, Masataka;
Owaki, Tetsuhiro;
Kita, Yoshiaki;
Natsugoe, Shoji

Publication type:

Article

Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 50, doi. 10.1007/s10120-011-0007-7

By:

Montagnani, Francesco;
Turrisi, Gina;
Marinozzi, Claudio;
Aliberti, Camillo;
Fiorentini, Giammaria

Publication type:

Article

Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 4, doi. 10.1007/s10120-011-0005-9

By:

Ubukata, Hideyuki;
Nagata, Hiroyuki;
Tabuchi, Takanobu;
Konishi, Satoru;
Kasuga, Teruhiko;
Tabuchi, Takafumi

Publication type:

Article

Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 22, doi. 10.1007/s10120-011-0001-0

By:

Oda, Ichiro;
Abe, Seiichiro;
Kusano, Chika;
Suzuki, Haruhisa;
Nonaka, Satoru;
Yoshinaga, Shigetaka;
Taniguchi, Hirokazu;
Shimoda, Tadakazu;
Gotoda, Takuji

Publication type:

Article

Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 28, doi. 10.1007/s10120-011-0003-y

By:

Iwasa, Satoru;
Yamada, Yasuhide;
Fukagawa, Takeo;
Nakajima, Takako Eguchi;
Kato, Ken;
Hamaguchi, Tetsuya;
Morita, Shinji;
Saka, Makoto;
Katai, Hitoshi;
Shimada, Yasuhiro

Publication type:

Article

Adjuvant chemoradiation for resected gastric cancer: a 10-year experience.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 63, doi. 10.1007/s10120-011-0011-y

By:

Chang, Amy T. Y.;
Wai Tong Ng;
Law, Ada L. Y.;
Ki Man Ku;
Lee, Michael C. H.;
Lee, Anne W. M.

Publication type:

Article

Depth-predicting score for differentiated early gastric cancer.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 35, doi. 10.1007/s10120-011-0002-z

By:

Abe, Seiichiro;
Oda, Ichiro;
Shimazu, Taichi;
Kinjo, Tetsu;
Tada, Kazuhiro;
Sakamoto, Taku;
Kusano, Chika;
Gotoda, Takuji

Publication type:

Article

Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 81, doi. 10.1007/s10120-011-0016-6

By:

Imamoto, Haruhiko;
Oba, Koji;
Sakamoto, Junichi;
Iishi, Hiroyasu;
Narahara, Hiroyuki;
Yumiba, Takeyoshi;
Morimoto, Takashi;
Nakamura, Masaki;
Oriuchi, Noboru;
Kakutani, Chieko;
Morita, Satoshi;
Shiozaki, Hitoshi

Publication type:

Article

Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 56, doi. 10.1007/s10120-011-0008-6

By:

Nonaka, Satoru;
Oda, Ichiro;
Nakaya, Teruo;
Kusano, Chika;
Suzuki, Haruhisa;
Yoshinaga, Shigetaka;
Fukagawa, Takeo;
Katai, Hitoshi;
Gotoda, Takuji

Publication type:

Article

Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 13, doi. 10.1007/s10120-011-0017-5

By:

Shimada, Hideaki;
Okazumi, Shinichi;
Koyama, Masamichi;
Murakami, Koji

Publication type:

Article

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Published in:

Gastric Cancer, 2011, v. 14, n. 1, p. 72, doi. 10.1007/s10120-011-0009-5

By:

Narahara, Hiroyuki;
Iishi, Hiroyasu;
Imamura, Hiroshi;
Tsuburaya, Akira;
Chin, Keisho;
Imamoto, Haruhiko;
Esaki, Taito;
Furukawa, Hiroshi;
Hamada, Chikuma;
Sakata, Yuh

Publication type:

Article

Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment.

Published in:

2011

By:

Takiuchi, Hiroya

Publication type:

Editorial